October 2015 – Page 2 – Policy & Medicine

FDA Removes Pacira Warning Letter in Midst of Free Speech Suit

Open Payments: Research Payments Distorted by Including Value of the Medicines and Devices

Orthopaedic Board May Use Surgeon Scorecard in Certification Process

FDA Establishes the Patient Engagement Advisory Committee

Senator Klobuchar Calls on FTC To Investigate Pharma Companies for Antitrust Violations in Wake of Turing Case

PharMerica to pay $9.25M in Dept. of Justice settlement

FDA Notice of PDUFA Reauthorization – Public Comments due April 29, 2016

District Court Grants Permanent Injunction Against Device Maker

Open Payments Analytics Webinar

Life Science Compliance Update: October Issue Covers Shifting Enforcement Priorities, First Amendment Challenges to FDA, New Settlement Provisions, Common Rule, and More